Exploring leptin antagonism in ophthalmic cell models.

Area of Science:

• Ophthalmology
• Endocrinology
• Cell Biology

Background:

• Leptin, a cytokine, is increasingly linked to ocular neovascularization.
• The therapeutic potential of inhibiting leptin in ophthalmic cells remains unexplored.

Purpose of the Study:

• To investigate leptin's mitogenic, angiogenic, and signaling activities in retinal and corneal endothelial cells.
• To evaluate the efficacy of a leptin receptor (ObR) antagonist, Allo-aca, in inhibiting these functions.

Main Methods:

• Experiments utilized monkey retinal (RF/6A) and bovine corneal (BCE) endothelial cells.
• Leptin's effects on cell proliferation and tube formation were assessed.
• The impact of Allo-aca on leptin-induced responses and signaling pathways (STAT3, Akt, ERK1/2, COX2, NFκB) was examined.

Main Results:

• Leptin significantly stimulated proliferation and angiogenic responses in both cell lines in a dose-dependent manner.
• Allo-aca (10-100 nM) effectively reduced leptin-induced proliferation and angiogenic responses.
• Leptin modulated key signaling molecules, and these effects were inhibited by Allo-aca (100 nM).
• Leptin exhibited autocrine effects on its own expression, which were blocked by Allo-aca (100-250 nM).

Conclusions:

• Leptin plays a significant role in ocular endothelial cell function, promoting proliferation and angiogenesis.
• Targeting the leptin receptor (ObR) with antagonists like Allo-aca shows promise for inhibiting pathological ocular neovascularization.